Squamous Cell Carcinoma of Head and Neck Clinical Trials in Boston, Massachusetts
4 recruitingBoston, Massachusetts
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer1,006 enrolled158 locationsNCT04389632
Recruiting
Early Phase 1
Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
Head and Neck CancerSquamous Cell Carcinoma of Head and NeckSalivary Gland Cancer+1 more
Brigham and Women's Hospital30 enrolled2 locationsNCT05553782
Recruiting
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
Squamous Cell Carcinoma of Head and Neck
Massachusetts Eye and Ear Infirmary75 enrolled1 locationNCT06744296
Recruiting
Phase 2
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
MelanomaSquamous Cell Carcinoma of Head and Neck
IO Biotech60 enrolled15 locationsNCT05280314